1. Lee
YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim
CT, Hohnen-Behrens
C. Berberine, a natural plant product, activates AMP-activated protein kinase
with beneficial metabolic effects in diabetic and insulin-resistant states.
Diabetes. 2006 Aug 1;55(8):2256-64.​

2. An
Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. The use of berberine for women with
polycystic ovary syndrome undergoing IVF treatment. Clinical endocrinology.
2014 Mar;80(3):425-31.​

3. Pérez-Rubio
KG, González-Ortiz M, Martínez-Abundis E,
Robles-Cervantes JA, Espinel-Bermúdez MC.
Effect of berberine administration on metabolic syndrome, insulin sensitivity,
and insulin secretion. Metabolic syndrome and related disorders. 2013 Oct
1;11(5):366-9.​

4. Yin
J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes
mellitus. Metabolism. 2008 May 1;57(5):712-7.​

5. Gu
Y, Zhang Y, Shi X, Li X, Hong J, Chen J, Gu W, Lu X, Xu G, Ning G. Effect of
traditional Chinese medicine berberine on type 2 diabetes based on
comprehensive metabonomics. Talanta.
2010 May 15;81(3):766-72.​

6. Derosa G,
D'Angelo A, Bonaventura A, Bianchi L, Romano D, Maffioli P.
Effects of berberine on lipid profile in subjects with low cardiovascular risk.
Expert opinion on biological therapy. 2013 Apr 1;13(4):475-82.​

7. Zhao
JV, Yeung WF, Chan YH, Vackova D,
Leung JY, Ip DK, Zhao J, Ho WK, Tse HF, Schooling CM. Effect of
berberine on cardiovascular disease risk factors: a mechanistic randomized
controlled trial. Nutrients. 2021 Jul 26;13(8):2550.​

8. Wei
W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y. A
clinical study on the short-term effect of berberine in comparison to metformin
on the metabolic characteristics of women with polycystic ovary
syndrome. European journal of endocrinology. 2012 Jan;166(1):99-105​

9. Hu
Y, Ehli EA, Kittelsrud J,
Ronan PJ, Munger K, Downey T, Bohlen K, Callahan L, Munson V, Jahnke M,
Marshall LL. Lipid-lowering effect of berberine in human subjects and rats.
Phytomedicine. 2012 Jul 15;19(10):861-7.​

10. Zhang
X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y, Li
X. Structural changes of gut microbiota during berberine-mediated prevention of
obesity and insulin resistance in high-fat diet-fed rats.​

11. Ilyas
Z, Perna S,
Al-Thawadi S, Alalwan TA,
Riva A, Petrangolini G, Gasparri C,
Infantino V, Peroni G, Rondanelli M.
The effect of Berberine on weight loss in order to prevent obesity: A
systematic review. Biomedicine & Pharmacotherapy. 2020 Jul
1;127:110137.​

12. Cheng
F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX,
Tao J. Berberine improves endothelial function by reducing endothelial
microparticles-mediated oxidative stress in humans. International journal of
cardiology. 2013 Aug 10;167(3):936-42.​

13. Ma
YG, Liang L, Zhang YB, Wang BF, Bai YG, Dai ZJ, Xie MJ, Wang ZW.
Berberine reduced blood pressure and improved vasodilation in diabetic rats.
Journal of molecular endocrinology. 2017 Oct 1;59(3):191-204.​

14. Ming
J, Yu X, Xu X, Wang L, Ding C, Wang Z, Xie X, Li S, Yang W, Luo S, He
Q. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and
their regulatory effect on the gut microbiota: a multi-center,
double-blind, randomized, parallel-controlled study. Genome Medicine. 2021
Dec;13(1):1-4.​

15. Shirwaikar A, Shirwaikar A,
Rajendran K, Punitha IS.
In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid
berberine. Biological and Pharmaceutical Bulletin. 2006;29(9):1906-10.​